China NMPA Drug Inspection - 49 companies including Anhui Huilong Traditional Chinese Medicine Pieces Co., Ltd. - Chinese herbal medicine slices

The Shandong Provincial Drug Administration issued an announcement on December 17, 2018, later published on November 18, 2019, detailing significant quality inspection failures. Inspections carried out by 13 drug testing institutions, including the Shandong Provincial Institute for Food and Drug Control, identified 65 batches of substandard drugs. This included three batches of medical institution preparations from entities such as Ningyang County Traditional Chinese Medicine Hospital, and 62 batches of traditional Chinese medicine decoction pieces from 49 enterprises, including Anhui Huilong Traditional Chinese Medicine Pieces Co., Ltd.

Operating under the regulatory authority of the Shandong Provincial Drug Administration, municipal food and drug administrations promptly implemented control measures. These actions involved sealing, seizing, suspending sales, and recalling the non-compliant products. Investigations and prosecutions have been initiated against the responsible manufacturers and sampled units in accordance with relevant laws and regulations. Additionally, administrations are mandated to enhance supervision, compelling enterprises to identify the root causes of these issues, formulate and implement effective rectification measures, and eliminate potential risks to ensure product quality and public safety.